Barcelona-based Oryzon Genomics SA, which is working in the field of epigenetics, has appointed Gregory Weaver as its chief financial officer to be based at the company’s US headquarters in Cambridge, Massachusetts. Mr Weaver has served as CFO at several public biotech companies including Fibrocell Science Inc, Celsion Corp, Poniard Pharmaceuticals Inc and Sirna Therapeutics Inc.
He earned his MBA from the Boston College Graduate School of Business and is licensed to practice accounting in both Massachusetts and Texas.
Oryzon announced the appointment on 12 January 2015.
Copyright 2015 Evernow Publishing Ltd